Previous 10 | Next 10 |
Zynex Announces 2020 Fourth Quarter and Full Year Earnings PR Newswire ENGLEWOOD, Colo. , Feb. 25, 2021 /PRNewswire/ -- 2020 Full Year Revenue increased 76% year over year to $80.1 million Orders increased 96% Net...
Zynex Schedules 2020 Fourth Quarter and Full-Year Earnings Call PR Newswire ENGLEWOOD, Colo., Feb. 18, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical ...
Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical PR Newswire ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive m...
Medical technology company Zynex (ZYXI) has filed for a provisional patent for a noninvasive sepsis monitor for treating the life-threatening medical condition characterised by the body-wide inflammatory response or reaction that presents in response to infection.The signs and sympt...
Zynex Announces Filing of Patent for Sepsis Monitor PR Newswire ENGLEWOOD, Colo. , Jan. 14, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...
Zynex ([[ZYXI]] +3.7%) reaffirms its previous revenue estimate for 4Q20 to be in rage of $25.5M and $26.5M vs. $25.60M consensus; and FY20 revenue estimate between $80M and $81M vs. $ 80.12M consensus.Zynex increases its adj. EBITDA estimate to between $3.1M and $4.1M (prior $2.3M and $3.3M);...
Zynex Announces 117% Year over Year Order Growth and Increases Adjusted EBITDA Estimate PR Newswire ENGLEWOOD, Colo. , Jan. 12, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and sellin...
Zynex exits Q3 with another sequential growth period in revenues and market share, with significant YoY comparisons. Valuations balance out to be attractive, and we feel shares are worth ~$27, based on gross profit multiples as a cleaner measure. Significant headwinds to operating...
Medical device maker Zynex ([[ZYXI]] +5.2%) announces that it has obtained a second U.S. Utility patent for its blood volume monitor device.Zynex's first generation CM-1500 device is cleared by the FDA and is already in full production.Thomas Sandgaard, CEO of Zynex, has a...
Zynex Announces a Second Utility Patent for Its Blood Volume Monitor PR Newswire ENGLEWOOD, Colo. , Jan. 6, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive med...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...